TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2023

The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting.

Olaf Wittenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.